Protecting renal function in the hypertensive patient: clinical guidelines

Area of Science:

• Nephrology
• Cardiology
• Endocrinology

Background:

• Chronic kidney disease (CKD) incidence and prevalence are increasing worldwide.
• Diabetes and hypertension significantly elevate risks for cardiovascular and renal events.
• Suboptimal control of blood glucose, blood pressure (BP), and lipids correlates with high morbidity and treatment costs.

Purpose of the Study:

• To highlight the importance of early CKD identification and management.
• To emphasize the need for targeted monitoring and treatment in hypertensive patients at risk for CKD.
• To discuss optimal antihypertensive strategies for preserving renal function.

Main Methods:

• Review of clinical trials and evidence regarding CKD, diabetes, and hypertension.
• Analysis of treatment goals for BP, albuminuria, and proteinuria.
• Evaluation of antihypertensive regimens, focusing on renin-angiotensin system blockade.

Main Results:

• Earlier CKD identification and treatment can prevent or delay cardiovascular events, renal failure, and premature death.
• Hypertensive patients represent a key subgroup requiring focused CKD monitoring and intervention.
• Optimal BP and proteinuria reduction is achieved with renin-angiotensin system blockers combined with other antihypertensive agents.

Conclusions:

• Effective management of diabetes and hypertension is crucial for preventing CKD complications.
• Targeted antihypertensive therapy, including renin-angiotensin system blockade, is essential for renal protection in CKD patients.
• Controlling BP and proteinuria is the primary clinical goal in treating CKD.